Trump’s use of malaria drug to prevent COVID-19 will likely be welcomed in India

Must Read

50 to 60 percent of SD60 students expected to return to class starting June 1

FORT ST. JOHN, B.C. - Many students across the province will be returning to school on Monday, June 1,...

BC sees another decrease in active cases, no new deaths reported as of Friday

VICTORIA, B.C. – The total number of confirmed COVID-19 cases in the Northern Health Region is still at 63...

Three new cases of COVID-19 reported in Grande Prairie

GRANDE PRAIRIE, A.B. - Alberta Health is reporting three new positive cases of COVID-19 in Grande Prairie.

U.S. President Donald Trump‘s declaration that he was taking an antimalarial drug of dubious effectiveness to help fend off the coronavirus will likely be welcomed in India.

Trump’s previous endorsement of hydroxychloroquine catalyzed a tremendous shift in the South Asian country, spurring the world’s largest producer of the drug to make much more of it, prescribe it for front-line health workers treating the virus and deploy it as a diplomatic tool, despite mounting evidence against using the drug for COVID-19.

- Advertisement -

Community Interviews with Moose FM


2:53Coronavirus outbreak: Trump reveals he’s been taking Hydroxychloroquine as preventative measure against COVID-19

Coronavirus outbreak: Trump reveals he’s been taking Hydroxychloroquine as preventative measure against COVID-19

Trump said Monday that he was taking hydroxychloroquine as a measure of protection against the virus. The U.S. Food and Drug Administration, however, has cautioned against using it outside of hospitals because of the risk of serious heart problems.

Suhhil Gupta, a pharmacist in New Delhi, said Tuesday that Trump’s announcement shouldn’t carry any weight in India.

Story continues below advertisement

“He’s not a pharmacist.

 » READ MORE FROM GLOBAL NEWS

More Articles Like This